Translational Development Acquisition Corp. - Ordinary Shares (TDAC)

10.80
-0.04 (-0.37%)
NASDAQ· Last Trade: Jul 29th, 12:13 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close10.84
Open10.84
Bid10.80
Ask10.82
Day's Range10.80 - 10.84
52 Week Range10.32 - 10.90
Volume38,195
Market Cap55.51M
PE Ratio (TTM)0.4365
EPS (TTM)24.7
Dividend & YieldN/A (N/A)
1 Month Average Volume21,527

Chart

News & Press Releases

ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
TAIPEI, Taiwan and NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Prologium Holding Inc. (“ProLogium” or the “Company”), a global leader in the innovation and manufacturing of next-generation lithium ceramic batteries, and Translational Development Acquisition Corp. (“TDAC”) (Nasdaq: TDAC), a special purpose acquisition company, today announced that ProLogium and TDAC have secured commitments for a $50 million primary capital investment from a consortium of existing ProLogium shareholders to support the previously announced business combination that would result in ProLogium becoming a publicly listed company (the “Transaction”).
ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.
TAIPEI, Taiwan and NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- ProLogium Holding Inc. (“ProLogium” or the “Company”), a global leader in the innovation and manufacturing of next-generation solid-state batteries, and Translational Development Acquisition Corp. ("TDAC") (Nasdaq: TDAC), a special purpose acquisition company, today announced they have entered into a definitive agreement for a business combination that would result in ProLogium becoming a publicly listed company (the “Transaction”).